Morgan Stanley’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-932
| Closed | -$4.98K | – | 8052 |
|
|
2023
Q4 | $4.98K | Buy |
932
+43
| +5% | +$265 | ﹤0.01% | 7006 |
|
|
2023
Q3 | $7.11K | Sell |
889
-536
| -38% | -$3.19K | ﹤0.01% | 6830 |
|
|
2023
Q2 | $6.06K | Sell |
1,425
-766
| -35% | -$4.34K | ﹤0.01% | 6940 |
|
|
2023
Q1 | $12.3K | Buy |
2,191
+261
| +14% | +$1.98K | ﹤0.01% | 6814 |
|
|
2022
Q4 | $16K | Sell |
1,930
-1,161
| -38% | -$22.7K | ﹤0.01% | 6767 |
|
|
2022
Q3 | $100K | Sell |
3,091
-733
| -19% | -$27.2K | ﹤0.01% | 6081 |
|
|
2022
Q2 | $153K | Buy |
3,824
+3,120
| +443% | +$228K | ﹤0.01% | 6021 |
|
|
2022
Q1 | $75K | Sell |
704
-6,532
| -90% | -$1.02M | ﹤0.01% | 6490 |
|
|
2021
Q4 | $1.8M | Buy |
7,236
+7,198
| +18,942% | +$1.6M | ﹤0.01% | 4655 |
|
|
2021
Q3 | $7K | Buy |
38
+34
| +850% | +$6.78K | ﹤0.01% | 7426 |
|
|
2021
Q2 | $1K | Sell |
4
-1
| -20% | -$203 | ﹤0.01% | 7655 |
|
|
2021
Q1 | $1K | Buy |
+5
| New | +$1.09K | ﹤0.01% | 7401 |
|
Morgan Stanley's SNCE Position: Q1 2024 in Review
Morgan Stanley sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 932 shares — an estimated $4.98K sold.
Morgan Stanley first reported a position in SNCE in Q1 2021 and held it in 12 quarters. The position peaked at $1.8M in Q4 2021. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.
- Morgan Stanley reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Morgan Stanley sold 932 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $4.98K.
- Morgan Stanley first reported a position in Science 37 Holdings, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
- Morgan Stanley's Science 37 Holdings, Inc. Common Stock position peaked at $1.8M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.